Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01288586 · ClinicalTrials.gov registry record
Post-Approval Study to Investigate the Long Term (8 Year) Survivorship of STAR Ankle Among Continued Access Study Patients
A clinical trial, sponsored by Stryker Trauma and Extremities.
- Completed
- Registry status
- 87
- Enrollment target
NCT01288586: Completed study, sponsored by Stryker Trauma and Extremities.
NCT01288586 is a clinical trial that has completed, run by Stryker Trauma and Extremities. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01288586 has completed, sponsored by Stryker Trauma and Extremities.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the long term survivorship of the Scandinavian Total Ankle Replacement (STAR). Specifically, this study focuses on the revision and/or removal rate of any component of the STAR ankle.
Primary Outcome
Obtain information on the revision and removal rate for the STAR Ankle over time.
Interventions
- DEVICE Scandinavian Total Ankle Replacement System (STAR Ankle)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2009-10-05 |
| Est. Completion | 2016-11-14 |
What the finished NCT01288586 record still lists
NCT01288586 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 87 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Scandinavian Total Ankle Replacement System (STAR Ankle) is the first listed.
NCT01288586 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01288586 about?
NCT01288586 is a clinical study titled "Post-Approval Study to Investigate the Long Term (8 Year) Survivorship of STAR Ankle Among Continued Access Study Patients". The purpose of this study is to examine the long term survivorship of the Scandinavian Total Ankle Replacement (STAR). Specifically, this study focuses on the revision and/or removal rate of any component of the STAR ankle.
What is the current status of trial NCT01288586?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2009-10-05. Estimated completion is 2016-11-14.
What interventions are being tested in trial NCT01288586?
The interventions under investigation include: Scandinavian Total Ankle Replacement System (STAR Ankle) (DEVICE).
Who is sponsoring clinical trial NCT01288586?
This trial is sponsored by Stryker Trauma and Extremities, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI